Bacillus subtilis strain NRRL B-67989

Information

Type

Compositional guidelines

Regulated products

Medical Devices

Topics

Complementary Medicines, Legislation, Listed Medicines, Prescription Medicines, Updates To Listed Medicine Ingredients

Published

June 14, 2024

Last updated

June 14, 2024

Description

Compositional Guideline for Bacillus subtilis strain NRRL B-67989 permitted for use in listed medicines.

Organization

Country / Region

Australia

License

Other (Non-Commercial)

Feedback

Suggest an improvement to this page

Actions

Social networks

Embed